About this trial
PANTOXBIL is a research project developed in the context of the increasing incidence of biliary tract and pancreatic cancers in France. Despite recent therapeutic advances, the prognosis of these cancers remains poor. Known risk factors do not fully explain the increase in incidence observed over recent decades. This suggests the possible role of emerging occupational and environmental risk factors, as reported in several epidemiological studies.
The PANTOXBIL study is based on the analysis of detailed curriculum laboris data (employment periods, occupations, tasks performed, and occupational exposures) collected during two multicenter phase II clinical trials, TEDOPAM and IMMUNOBIL, conducted between 2018 and 2021 in patients with pancreatic and biliary tract cancers.
An occupational exposure assessment was performed to calculate semi-quantitative cumulative exposure indices for each exposure or group of exposures for every participant. These indices will be compared with those of healthy controls from the CHOPPI cohort, initially designed to study occupational risk factors in COPD.
PANTOXBIL is a matched case-control study based on sex, age, and smoking status. The aim is to compare cumulative occupational exposure indices between cases and controls in order to generate new hypotheses regarding occupational risk factors for biliary tract and pancreatic cancers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients included in the TEDOPAM or IMMUNOBIL trials
Diagnosis of biliary tract or pancreatic cancer
Completed and exploitable curriculum laboris
Subjects from the CHOPPI cohort
Disqualifiers
Incomplete or non-exploitable occupational history
Refusal of data reuse
Trial population
Patients with pancreatic and biliary tract cancers included during two multicenter phase II clinical trials (cases) Control patients without pancreatic and biliary tract cancers from the CHOPPI cohort
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Compare the occupational exposure index to targeted toxicants
Compare the occupational exposure index to targeted toxicants, calculated from curriculum laboris, between patients with biliary-pancreatic cancers and controls without biliary-pancreatic cancers, in order to estimate for each toxicant an odds ratio and to identify occupational exposures potentially involved in the occurrence of these cancers
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Centre Hospitalier Intercommunal Creteil
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Collaborator
This trial is not recruiting at the moment. You can still explore other options: